Mylan NV Profile


Odds of Distress

Analyze Filter    Fiscal Quarter End: December 31, 2019
Equity ratings for Mylan NV are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 7, 2019 and ending today December 6, 2019. Click here to learn more.

Mylan NV Profile

Next fiscal quarter end is expected on December 31, 2019. Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter pharmaceutical products in North America, Europe, and internationally. The company was founded in 1961 and is based in Hatfield, the United Kingdom. Mylan NV operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 35000 people. more
Mylan NV Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Mylan NV SEC Filings
Mylan NV SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameMylan NV
CEOHeather BreschView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - Specialty & Generic
InstrumentUSA Stock View All
LocationUnited Kingdom
Business AddressBuilding 4
Foreign Associate  Austria
ExchangeBATS Exchange
IndustryDrug Manufacturers?Specialty & Generic
Phone44 1707 853 000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Mylan NV (MYL) is traded on BATS Exchange in USA. It is located in Building 4 and employs 35,000 people. Mylan NV is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 8.59 B. Mylan NV runs under Healthcare sector within Drug Manufacturers?Specialty & Generic industry. The entity has 515.87 M outstanding shares of which 25.69 M shares are now shorted by investors with about 3.63 days to cover shorted positions. MYLAN INC has about 299.2 M in cash with 2.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check Mylan NV Probability Of Bankruptcy

Ownership Allocation (%)

Mylan NV Target Price Odds Analysis

Odds Below 19.28HorizonTargetOdds Above 19.28
56.00%30 days 19.28 43.82%
Based on normal probability distribution, the odds of Mylan NV to move above current price in 30 days from now is about 43.82 (This Mylan NV probability density function shows the probability of Mylan NV Stock to fall within a particular range of prices over 30 days) .

Mylan NV Top Holders

Mylan NV Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Mylan NV Key Fundamentals

Mylan NV Against Markets

Did you try this?

Run Commodity Channel Index Now


Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Mylan NV Upcoming and Recent Events

Mylan NV Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 25, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 25, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Mylan NV Corporate Filings

Mylan NV SEC Reporting

Other Events
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
Unclassified Corporate Event
Regulation FD Disclosure. Submission of Matters to a Vote of Security Holders

Mylan NV Corporate Directors

Joseph Maroon Independent Director
Harry Korman Non-Executive Independent Director
Melina Higgins Independent Director
Please see also Stocks Correlation. Please also try Market Hitters module to find equities that experience drastic asymmetry in trading patters, price, volume, or investment outlook..